9-127744627-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_170600.3(SH2D3C):c.1737G>A(p.Lys579=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00804 in 1,614,034 control chromosomes in the GnomAD database, including 127 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0062 ( 8 hom., cov: 30)
Exomes 𝑓: 0.0082 ( 119 hom. )
Consequence
SH2D3C
NM_170600.3 synonymous
NM_170600.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.767
Genes affected
SH2D3C (HGNC:16884): (SH2 domain containing 3C) This gene encodes an adaptor protein and member of a cytoplasmic protein family involved in cell migration. The encoded protein contains a putative Src homology 2 (SH2) domain and guanine nucleotide exchange factor-like domain which allows this signaling protein to form a complex with scaffolding protein Crk-associated substrate. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 9-127744627-C-T is Benign according to our data. Variant chr9-127744627-C-T is described in ClinVar as [Benign]. Clinvar id is 775279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.767 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00619 (943/152314) while in subpopulation SAS AF= 0.0226 (109/4828). AF 95% confidence interval is 0.0191. There are 8 homozygotes in gnomad4. There are 453 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2D3C | NM_170600.3 | c.1737G>A | p.Lys579= | synonymous_variant | 7/12 | ENST00000314830.13 | NP_733745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH2D3C | ENST00000314830.13 | c.1737G>A | p.Lys579= | synonymous_variant | 7/12 | 1 | NM_170600.3 | ENSP00000317817 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00618 AC: 940AN: 152196Hom.: 8 Cov.: 30
GnomAD3 genomes
AF:
AC:
940
AN:
152196
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00870 AC: 2187AN: 251404Hom.: 28 AF XY: 0.00976 AC XY: 1326AN XY: 135878
GnomAD3 exomes
AF:
AC:
2187
AN:
251404
Hom.:
AF XY:
AC XY:
1326
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00824 AC: 12040AN: 1461720Hom.: 119 Cov.: 31 AF XY: 0.00889 AC XY: 6462AN XY: 727122
GnomAD4 exome
AF:
AC:
12040
AN:
1461720
Hom.:
Cov.:
31
AF XY:
AC XY:
6462
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00619 AC: 943AN: 152314Hom.: 8 Cov.: 30 AF XY: 0.00608 AC XY: 453AN XY: 74478
GnomAD4 genome
AF:
AC:
943
AN:
152314
Hom.:
Cov.:
30
AF XY:
AC XY:
453
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
29
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at